# Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy

> **NCT06926543** · PHASE3 · RECRUITING · sponsor: **Dr. Tabassum Wadasadawala** · enrollment: 858 (estimated)

## Conditions studied

- Invasive Breast Cancer
- Stage III Breast Cancer
- Stage IIB Breast Cancer

## Interventions

- **DRUG:** Chemoradiation
- **DRUG:** Chemoradiation

## Key facts

- **NCT ID:** NCT06926543
- **Lead sponsor:** Dr. Tabassum Wadasadawala
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-14
- **Primary completion:** 2031-05
- **Final completion:** 2031-05
- **Target enrollment:** 858 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06926543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06926543, "Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06926543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*